Caroline N. Dealy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Caroline N. Dealy has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Melanie Fisher
University of Connecticut Health
3 shared publications - Deborah Kaback
Department of Cell Biology, University of Connecticut Health Center, Farmington, United States
2 shared publications - Jeremy R. Egbert
Department of Cell Biology, University of Connecticut Health Center
2 shared publications - Laurinda A. Jaffe
Department of Cell Biology, University of Connecticut Health Center , Farmington, CT 06030
2 shared publications - Leia C. Shuhaibar
Department of Cell Biology, University of Connecticut Health Center, Farmington CT 06030 USA
2 shared publications - Lincoln R. Potter
University of Minnesota
2 shared publications
Latest Publications
- 27 November 2021
- Published by Wiley in Developmental Dynamics
- Vol. 251 (1) , 193-212
Cross‐talk between EGFR and BMP signals regulates chondrocyte maturation during endochondral ossification
Background: Progressive maturation of growth plate chondrocytes drives long bone growth during endochondral ossification. Signals from the epidermal growth factor receptor (EGFR), and from bone morphogenetic protein‐2 (BMP2), are required for normal chondrocyte maturation. Here, we investigated cross‐talk between EGFR and BMP2 signals in developing and adult growth plates.Results: Using in vivo mouse models of conditional cartilage‐targeted EGFR or BMP2 loss, we show that canonical BMP signal activation is increased in the hypertrophic chondrocytes of EGFR‐deficient growth plates; whereas EGFR signal activation is increased in the reserve, prehypertrophic and hypertrophic chondrocytes of BMP2‐deficient growth plates. EGFR‐deficient chondrocytes displayed increased BMP signal activation in vitro, accompanied by increased expression of IHH, COL10A1, and RUNX2. Hypertrophic differentiation and BMP signal activation were suppressed in normal chondrocyte cultures treated with the EGFR ligand betacellulin, effects that were partially blocked by simultaneous treatment with BMP2 or a chemical EGFR antagonist.Conclusions: Cross‐talk between EGFR and BMP2 signals occurs during chondrocyte maturation. In the reserve and prehypertrophic zones, BMP2 signals unilaterally suppress EGFR activity; in the hypertrophic zone, EGFR and BMP2 signals repress each other. This cross‐talk may play a role in regulating chondrocyte maturation in developing and adult growth plates.
- 27 November 2021
- Published by Wiley in Developmental Dynamics
- Vol. 251 (1) , 193-212
Cross‐talk between EGFR and BMP signals regulates chondrocyte maturation during endochondral ossification
Background: Progressive maturation of growth plate chondrocytes drives long bone growth during endochondral ossification. Signals from the epidermal growth factor receptor (EGFR), and from bone morphogenetic protein‐2 (BMP2), are required for normal chondrocyte maturation. Here, we investigated cross‐talk between EGFR and BMP2 signals in developing and adult growth plates.Results: Using in vivo mouse models of conditional cartilage‐targeted EGFR or BMP2 loss, we show that canonical BMP signal activation is increased in the hypertrophic chondrocytes of EGFR‐deficient growth plates; whereas EGFR signal activation is increased in the reserve, prehypertrophic and hypertrophic chondrocytes of BMP2‐deficient growth plates. EGFR‐deficient chondrocytes displayed increased BMP signal activation in vitro, accompanied by increased expression of IHH, COL10A1, and RUNX2. Hypertrophic differentiation and BMP signal activation were suppressed in normal chondrocyte cultures treated with the EGFR ligand betacellulin, effects that were partially blocked by simultaneous treatment with BMP2 or a chemical EGFR antagonist.Conclusions: Cross‐talk between EGFR and BMP2 signals occurs during chondrocyte maturation. In the reserve and prehypertrophic zones, BMP2 signals unilaterally suppress EGFR activity; in the hypertrophic zone, EGFR and BMP2 signals repress each other. This cross‐talk may play a role in regulating chondrocyte maturation in developing and adult growth plates.
- 13 September 2018
- Published by Elsevier
- p. 660-676
Osteoarthritis at the Cellular Level: Mechanisms, Clinical Perspectives, and Insights From Development
- 13 September 2018
- Published by Elsevier
- p. 660-676
Osteoarthritis at the Cellular Level: Mechanisms, Clinical Perspectives, and Insights From Development
- Open Access
- 4 December 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor
Activating mutations in fibroblast growth factor (FGF) receptor 3 and inactivating mutations in the NPR2 guanylyl cyclase both cause severe short stature, but how these two signaling systems interact to regulate bone growth is poorly understood. Here, we show that bone elongation is increased when NPR2 cannot be dephosphorylated and thus produces more cyclic GMP. By developing an in vivo imaging system to measure cyclic GMP production in intact tibia, we show that FGF-induced dephosphorylation of NPR2 decreases its guanylyl cyclase activity in growth plate chondrocytes in living bone. The dephosphorylation requires a PPP-family phosphatase. Thus FGF signaling lowers cyclic GMP production in the growth plate, which counteracts bone elongation. These results define a new component of the signaling network by which activating mutations in the FGF receptor inhibit bone growth.
- 4 December 2017
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 6
Open AccessDephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor
Activating mutations in fibroblast growth factor (FGF) receptor 3 and inactivating mutations in the NPR2 guanylyl cyclase both cause severe short stature, but how these two signaling systems interact to regulate bone growth is poorly understood. Here, we show that bone elongation is increased when NPR2 cannot be dephosphorylated and thus produces more cyclic GMP. By developing an in vivo imaging system to measure cyclic GMP production in intact tibia, we show that FGF-induced dephosphorylation of NPR2 decreases its guanylyl cyclase activity in growth plate chondrocytes in living bone. The dephosphorylation requires a PPP-family phosphatase. Thus FGF signaling lowers cyclic GMP production in the growth plate, which counteracts bone elongation. These results define a new component of the signaling network by which activating mutations in the FGF receptor inhibit bone growth.
- Open Access
Dephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor
Activating mutations in fibroblast growth factor (FGF) receptor 3 and inactivating mutations in the NPR2 guanylyl cyclase cause similar forms of dwarfism, but how these two signaling systems interact to regulate bone growth is poorly understood. Here, by use of a mouse model in which NPR2 cannot be dephosphorylated, we show that bone elongation is opposed when NPR2 is dephosphorylated and thus produces less cyclic GMP. By developing an in vivo imaging system to measure cyclic GMP levels in intact tibia, we show that FGF-induced dephosphorylation of NPR2 decreases its guanylyl cyclase activity in growth plate chondrocytes in living bone. Thus FGF signaling lowers cyclic GMP in the growth plate, which counteracts bone elongation. These results define a new component of the signaling network by which activating mutations in the FGF receptor inhibit bone growth.
Open AccessDephosphorylation of the NPR2 guanylyl cyclase contributes to inhibition of bone growth by fibroblast growth factor
Activating mutations in fibroblast growth factor (FGF) receptor 3 and inactivating mutations in the NPR2 guanylyl cyclase cause similar forms of dwarfism, but how these two signaling systems interact to regulate bone growth is poorly understood. Here, by use of a mouse model in which NPR2 cannot be dephosphorylated, we show that bone elongation is opposed when NPR2 is dephosphorylated and thus produces less cyclic GMP. By developing an in vivo imaging system to measure cyclic GMP levels in intact tibia, we show that FGF-induced dephosphorylation of NPR2 decreases its guanylyl cyclase activity in growth plate chondrocytes in living bone. Thus FGF signaling lowers cyclic GMP in the growth plate, which counteracts bone elongation. These results define a new component of the signaling network by which activating mutations in the FGF receptor inhibit bone growth.
- Open Access
- 1 August 2002
- Published by Wiley in Development, Growth & Differentiation
- Vol. 44 (4) , 315-325
β‐Catenin‐dependent Wnt signaling in apical ectodermal ridge induction and FGF8 expression in normal and limbless mutant chick limbs
The fibroblast growth factor (FGF) and β‐catenin‐dependent Wnt signaling pathways are key regulators of vertebrate limb development. FGF10 induces expression of Wnt3a, which regulates the formation and FGF8 expression of the apical ectodermal ridge (AER). In amelic limbless limbs, an AER fails to form and FGF8 is not expressed, despite expression of FGF10. It has been found that Wnt3a is initially expressed in limbless ectoderm, although subsequently is drastically reduced. In addition, changes in the expression pattern or level of several Frizzled receptors, Axin, Lef1/Tcf1 and β‐catenin have been found in limbless limbs. Notably, while normal wing buds respond to LiCl‐stimulated activation of β‐catenin‐dependent signaling by forming ectopic, FGF8‐expressing AER, LiCl was unable to induce an AER in limbless wing buds. The results of this study suggest that the limbless gene is required for β‐catenin‐dependent Wnt signaling in limb ectoderm leading to FGF8 expression and AER formation.
- 1 August 2002
- Published by Wiley in Development, Growth & Differentiation
- Vol. 44 (4) , 315-325
Open Accessβ‐Catenin‐dependent Wnt signaling in apical ectodermal ridge induction and FGF8 expression in normal and limbless mutant chick limbs
The fibroblast growth factor (FGF) and β‐catenin‐dependent Wnt signaling pathways are key regulators of vertebrate limb development. FGF10 induces expression of Wnt3a, which regulates the formation and FGF8 expression of the apical ectodermal ridge (AER). In amelic limbless limbs, an AER fails to form and FGF8 is not expressed, despite expression of FGF10. It has been found that Wnt3a is initially expressed in limbless ectoderm, although subsequently is drastically reduced. In addition, changes in the expression pattern or level of several Frizzled receptors, Axin, Lef1/Tcf1 and β‐catenin have been found in limbless limbs. Notably, while normal wing buds respond to LiCl‐stimulated activation of β‐catenin‐dependent signaling by forming ectopic, FGF8‐expressing AER, LiCl was unable to induce an AER in limbless wing buds. The results of this study suggest that the limbless gene is required for β‐catenin‐dependent Wnt signaling in limb ectoderm leading to FGF8 expression and AER formation.